-
1
-
-
79952232216
-
Global cancer statistics
-
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011; 61:69-90.
-
(2011)
CA Cancer J Clin
, vol.61
, pp. 69-90
-
-
Jemal, A.1
Bray, F.2
Center, M.M.3
Ferlay, J.4
Ward, E.5
Forman, D.6
-
2
-
-
84902097348
-
RAGE mediates S100A4-induced cell motility via MAPK/ERK and hypoxia signaling and is a prognostic biomarker for human colorectal cancer metastasis
-
Dahlmann M, Okhrimenko A, Marcinkowski P, Osterland M, Herrmann P, Smith J, Heizmann CW, Schlag PM, Stein U. RAGE mediates S100A4-induced cell motility via MAPK/ERK and hypoxia signaling and is a prognostic biomarker for human colorectal cancer metastasis. Oncotarget. 2014; 5:3220-3233.
-
(2014)
Oncotarget
, vol.5
, pp. 3220-3233
-
-
Dahlmann, M.1
Okhrimenko, A.2
Marcinkowski, P.3
Osterland, M.4
Herrmann, P.5
Smith, J.6
Heizmann, C.W.7
Schlag, P.M.8
Stein, U.9
-
3
-
-
81255188940
-
Tumor angiogenesis: molecular pathways and therapeutic targets
-
Weis SM, Cheresh DA. Tumor angiogenesis: molecular pathways and therapeutic targets. Nat Med. 2011; 17:1359-1370.
-
(2011)
Nat Med
, vol.17
, pp. 1359-1370
-
-
Weis, S.M.1
Cheresh, D.A.2
-
4
-
-
79956328903
-
Molecular mechanisms and clinical applications of angiogenesis
-
Carmeliet P, Jain RK. Molecular mechanisms and clinical applications of angiogenesis. Nature. 2011; 473:298-307.
-
(2011)
Nature
, vol.473
, pp. 298-307
-
-
Carmeliet, P.1
Jain, R.K.2
-
5
-
-
84921963991
-
-
Seminars in cancer biology. Academic Press, Elsevier
-
Wang Z, Dabrosin C, Yin X, Fuster MM, Arreola A, Rathmell WK, Generali D, Nagaraju GP, El-Rayes B, Ribatti D. Broad targeting of angiogenesis for cancer prevention and therapy. Seminars in cancer biology. Academic Press, Elsevier, 2015.
-
(2015)
Broad targeting of angiogenesis for cancer prevention and therapy
-
-
Wang, Z.1
Dabrosin, C.2
Yin, X.3
Fuster, M.M.4
Arreola, A.5
Rathmell, W.K.6
Generali, D.7
Nagaraju, G.P.8
El-Rayes, B.9
Ribatti, D.10
-
6
-
-
85013312416
-
Tumor angiogenesis: therapeutic implications
-
Folkman J. Tumor angiogenesis: therapeutic implications. New Engl J Med. 1971; 285:1182-1186.
-
(1971)
New Engl J Med
, vol.285
, pp. 1182-1186
-
-
Folkman, J.1
-
7
-
-
84920031398
-
Reduced miR-126 expression facilitates angiogenesis of gastric cancer through its regulation on VEGF-A
-
Chen H, Li L, Wang S, Lei Y, Ge Q, Lv N, Zhou X, Chen C. Reduced miR-126 expression facilitates angiogenesis of gastric cancer through its regulation on VEGF-A. Oncotarget. 2014; 5:11873-11885.
-
(2014)
Oncotarget
, vol.5
, pp. 11873-11885
-
-
Chen, H.1
Li, L.2
Wang, S.3
Lei, Y.4
Ge, Q.5
Lv, N.6
Zhou, X.7
Chen, C.8
-
9
-
-
58149232586
-
The interleukin-8 pathway in cancer
-
Waugh DJJ, Wilson C. The interleukin-8 pathway in cancer. Clin Cancer Res. 2008; 14:6735-6741.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 6735-6741
-
-
Waugh, D.J.J.1
Wilson, C.2
-
10
-
-
84878462367
-
Role of MIF/CXCL8/CXCR2 signaling in the growth of nasopharyngeal carcinoma tumor spheres
-
Lo M, Yip T, Ngan K, Cheng W, Law C, Chan P, Chan K, Wong CK, Wong RN, Lo K, et al. Role of MIF/CXCL8/CXCR2 signaling in the growth of nasopharyngeal carcinoma tumor spheres. Cancer Lett. 2013; 335:81-92.
-
(2013)
Cancer Lett
, vol.335
, pp. 81-92
-
-
Lo, M.1
Yip, T.2
Ngan, K.3
Cheng, W.4
Law, C.5
Chan, P.6
Chan, K.7
Wong, C.K.8
Wong, R.N.9
Lo, K.10
-
11
-
-
69249155331
-
Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human malignant melanoma progression
-
Gabellini C, Trisciuoglio D, Desideri M, Candiloro A, Ragazzoni Y, Orlandi A, Zupi G, Del Bufalo D. Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human malignant melanoma progression. Eur J Cancer. 2009; 45:2618-2627.
-
(2009)
Eur J Cancer
, vol.45
, pp. 2618-2627
-
-
Gabellini, C.1
Trisciuoglio, D.2
Desideri, M.3
Candiloro, A.4
Ragazzoni, Y.5
Orlandi, A.6
Zupi, G.7
Del Bufalo, D.8
-
12
-
-
84873333749
-
Targeting CXCR1/2 significantly reduces breast cancer stem cell activity and increases the efficacy of inhibiting HER2 via HER2-dependent and-independent mechanisms
-
Singh JK, Farnie G, Bundred NJ, Simoes BM, Shergill A, Landberg G, Howell SJ, Clarke RB. Targeting CXCR1/2 significantly reduces breast cancer stem cell activity and increases the efficacy of inhibiting HER2 via HER2-dependent and-independent mechanisms. Clin Cancer Res. 2013; 19:643-656.
-
(2013)
Clin Cancer Res
, vol.19
, pp. 643-656
-
-
Singh, J.K.1
Farnie, G.2
Bundred, N.J.3
Simoes, B.M.4
Shergill, A.5
Landberg, G.6
Howell, S.J.7
Clarke, R.B.8
-
13
-
-
84887251722
-
Tumour angiogenesis regulation by the miR-200 family
-
Pecot CV, Rupaimoole R, Yang D, Akbani R, Ivan C, Lu C, Wu S, Han H, Shah MY, Rodriguez-Aguayo C, et al. Tumour angiogenesis regulation by the miR-200 family. Nat Commun. 2013; 4:2427.
-
(2013)
Nat Commun
, vol.4
, pp. 2427
-
-
Pecot, C.V.1
Rupaimoole, R.2
Yang, D.3
Akbani, R.4
Ivan, C.5
Lu, C.6
Wu, S.7
Han, H.8
Shah, M.Y.9
Rodriguez-Aguayo, C.10
-
14
-
-
77954084304
-
The interleukin-8-251 AA genotype is associated with angiogenesis in gastric carcinogenesis in Helicobacter pylori-infected Koreans
-
Song JH, Kim SG, Jung S, Lee MK, Jung HC, Song IS. The interleukin-8-251 AA genotype is associated with angiogenesis in gastric carcinogenesis in Helicobacter pylori-infected Koreans. Cytokine. 2010; 51:158-165.
-
(2010)
Cytokine
, vol.51
, pp. 158-165
-
-
Song, J.H.1
Kim, S.G.2
Jung, S.3
Lee, M.K.4
Jung, H.C.5
Song, I.S.6
-
15
-
-
79952471898
-
Interleukin-8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models
-
Ning Y, Manegold PC, Hong YK, Zhang W, Pohl A, Lurje G, Winder T, Yang D, LaBonte MJ, Wilson PM, Ladner RD, Lenz H. Interleukin-8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models. Int J Cancer. 2011; 128:2038-2049.
-
(2011)
Int J Cancer
, vol.128
, pp. 2038-2049
-
-
Ning, Y.1
Manegold, P.C.2
Hong, Y.K.3
Zhang, W.4
Pohl, A.5
Lurje, G.6
Winder, T.7
Yang, D.8
LaBonte, M.J.9
Wilson, P.M.10
Ladner, R.D.11
Lenz, H.12
-
16
-
-
84869491266
-
Mesenchymal stem cell signaling in cancer progression
-
Torsvik A, Bjerkvig R. Mesenchymal stem cell signaling in cancer progression. Cancer Treat Rev. 2013; 39:180-188.
-
(2013)
Cancer Treat Rev
, vol.39
, pp. 180-188
-
-
Torsvik, A.1
Bjerkvig, R.2
-
17
-
-
84864952801
-
Mesenchymal stem cells in tumor development
-
Cuiffo BG, Karnoub AE. Mesenchymal stem cells in tumor development. Cell Adhes Migration. 2012; 6:220-230.
-
(2012)
Cell Adhes Migration
, vol.6
, pp. 220-230
-
-
Cuiffo, B.G.1
Karnoub, A.E.2
-
18
-
-
84874666281
-
Bone marrow-derived mesenchymal stem cells promote colorectal cancer progression through paracrine neuregulin 1/HER3 signalling
-
De Boeck A, Pauwels P, Hensen K, Rummens J, Westbroek W, Hendrix A, Maynard D, Denys H, Lambein K, Braems G, Gespach C, Bracke M, Wever OD. Bone marrow-derived mesenchymal stem cells promote colorectal cancer progression through paracrine neuregulin 1/HER3 signalling. Gut. 2013; 62:550-560.
-
(2013)
Gut
, vol.62
, pp. 550-560
-
-
De Boeck, A.1
Pauwels, P.2
Hensen, K.3
Rummens, J.4
Westbroek, W.5
Hendrix, A.6
Maynard, D.7
Denys, H.8
Lambein, K.9
Braems, G.10
Gespach, C.11
Bracke, M.12
Wever, O.D.13
-
19
-
-
84857411051
-
Origins of the tumor microenvironment: quantitative assessment of adipose-derived and bone marrow-derived stroma
-
Kidd S, Spaeth E, Watson K, Burks J, Lu H, Klopp A, Andreeff M, Marini FC. Origins of the tumor microenvironment: quantitative assessment of adipose-derived and bone marrow-derived stroma. PLOS ONE. 2012; 7:e30563.
-
(2012)
PLOS ONE
, vol.7
-
-
Kidd, S.1
Spaeth, E.2
Watson, K.3
Burks, J.4
Lu, H.5
Klopp, A.6
Andreeff, M.7
Marini, F.C.8
-
20
-
-
77954564230
-
Bone marrow-derived mesenchymal stem cells and the tumor microenvironment
-
Bergfeld SA, DeClerck YA. Bone marrow-derived mesenchymal stem cells and the tumor microenvironment. Cancer Metastasis Rev. 2010; 29:249-261.
-
(2010)
Cancer Metastasis Rev
, vol.29
, pp. 249-261
-
-
Bergfeld, S.A.1
DeClerck, Y.A.2
-
21
-
-
80052122372
-
Mesenchymal stem cells promote formation of colorectal tumors in mice
-
Tsai K, Yang S, Lei Y, Tsai C, Chen H, Hsu C, Chen L, Wang H, Miller SA, Chiou S, Hung M, Hung S. Mesenchymal stem cells promote formation of colorectal tumors in mice. Gastroenterology. 2011; 141:1046-1056.
-
(2011)
Gastroenterology
, vol.141
, pp. 1046-1056
-
-
Tsai, K.1
Yang, S.2
Lei, Y.3
Tsai, C.4
Chen, H.5
Hsu, C.6
Chen, L.7
Wang, H.8
Miller, S.A.9
Chiou, S.10
Hung, M.11
Hung, S.12
-
22
-
-
84860217708
-
Mesenchymal stem cells in the colorectal tumor microenvironment: recent progress and implications
-
Hogan NM, Dwyer RM, Joyce MR, Kerin MJ. Mesenchymal stem cells in the colorectal tumor microenvironment: recent progress and implications. Int J Cancer. 2012; 131:1-7.
-
(2012)
Int J Cancer
, vol.131
, pp. 1-7
-
-
Hogan, N.M.1
Dwyer, R.M.2
Joyce, M.R.3
Kerin, M.J.4
-
23
-
-
39449107724
-
In vitro secreting profile of human mesenchymal stem cells
-
Schinköthe T, Bloch W, Schmidt A. In vitro secreting profile of human mesenchymal stem cells. Stem Cells Dev. 2008; 17:199-206.
-
(2008)
Stem Cells Dev
, vol.17
, pp. 199-206
-
-
Schinköthe, T.1
Bloch, W.2
Schmidt, A.3
-
24
-
-
79960130552
-
Effects of inflammatory factors on mesenchymal stem cells and their role in the promotion of tumor angiogenesis in colon cancer
-
Liu Y, Han Z, Zhang S, Jing Y, Bu X, Wang C, Sun K, Jiang G, Zhao X, Li R, et al. Effects of inflammatory factors on mesenchymal stem cells and their role in the promotion of tumor angiogenesis in colon cancer. J Biol Chem. 2011; 286:25007-25015.
-
(2011)
J Biol Chem
, vol.286
, pp. 25007-25015
-
-
Liu, Y.1
Han, Z.2
Zhang, S.3
Jing, Y.4
Bu, X.5
Wang, C.6
Sun, K.7
Jiang, G.8
Zhao, X.9
Li, R.10
-
25
-
-
62949144392
-
Bone marrow-derived cells and tumor growth: contribution of bone marrow-derived cells to tumor micro-environments with special focus on mesenchymal stem cells
-
Roorda BD, ter Elst A, Kamps WA. Bone marrow-derived cells and tumor growth: contribution of bone marrow-derived cells to tumor micro-environments with special focus on mesenchymal stem cells. Crit Rev Oncol/Hematol. 2009; 69:187-198.
-
(2009)
Crit Rev Oncol/Hematol
, vol.69
, pp. 187-198
-
-
Roorda, B.D.1
ter Elst, A.2
Kamps, W.A.3
-
26
-
-
84862012508
-
The role of mesenchymal stem cells in anti-cancer drug resistance and tumour progression
-
Houthuijzen JM, Daenen LGM, Roodhart JML, Voest EE. The role of mesenchymal stem cells in anti-cancer drug resistance and tumour progression. Brit J Cancer. 2012; 106:1901-1906.
-
(2012)
Brit J Cancer
, vol.106
, pp. 1901-1906
-
-
Houthuijzen, J.M.1
Daenen, L.G.M.2
Roodhart, J.M.L.3
Voest, E.E.4
-
27
-
-
79960720038
-
Mesenchymal stromal cells promote tumor growth through the enhancement of neovascularization
-
Suzuki K, Sun R. Mesenchymal stromal cells promote tumor growth through the enhancement of neovascularization. Mol Med. 2011; 17:1.
-
(2011)
Mol Med
, vol.17
, pp. 1
-
-
Suzuki, K.1
Sun, R.2
-
28
-
-
49549092228
-
VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma
-
Beckermann BM, Kallifatidis G, Groth A, Frommhold D, Apel A, Mattern J, Salnikov AV, Moldenhauer G, Wagner W, Diehlmann A, et al. VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma. Brit J Cancer. 2008; 99:622-631.
-
(2008)
Brit J Cancer
, vol.99
, pp. 622-631
-
-
Beckermann, B.M.1
Kallifatidis, G.2
Groth, A.3
Frommhold, D.4
Apel, A.5
Mattern, J.6
Salnikov, A.V.7
Moldenhauer, G.8
Wagner, W.9
Diehlmann, A.10
-
29
-
-
79951982581
-
Mesenchymal stem cells stimulate angiogenesis in a murine xenograft model of A549 human adenocarcinoma through an LPA1 receptor-dependent mechanism
-
Jeon ES, Lee IH, Heo SC, Shin SH, Choi YJ, Park JH, Park DY, Kim JH. Mesenchymal stem cells stimulate angiogenesis in a murine xenograft model of A549 human adenocarcinoma through an LPA1 receptor-dependent mechanism. Biochim Biophys Acta (BBA)-Mol Cell Biol Lipids. 2010; 1801:1205-1213.
-
(2010)
Biochim Biophys Acta (BBA)-Mol Cell Biol Lipids
, vol.1801
, pp. 1205-1213
-
-
Jeon, E.S.1
Lee, I.H.2
Heo, S.C.3
Shin, S.H.4
Choi, Y.J.5
Park, J.H.6
Park, D.Y.7
Kim, J.H.8
-
30
-
-
84884204620
-
Mesenchymal stem cells promote growth and angiogenesis of tumors in mice
-
Huang W, Chang M, Tsai K, Hung M, Chen H, Hung S. Mesenchymal stem cells promote growth and angiogenesis of tumors in mice. Oncogene. 2013; 32:4343-4354.
-
(2013)
Oncogene
, vol.32
, pp. 4343-4354
-
-
Huang, W.1
Chang, M.2
Tsai, K.3
Hung, M.4
Chen, H.5
Hung, S.6
-
31
-
-
84871599135
-
Human bone marrow-derived mesenchymal stem cells suppress human glioma growth through inhibition of angiogenesis
-
Ho IAW, Toh HC, Ng WH, Teo YL, Guo CM, Hui KM, Lam PYP. Human bone marrow-derived mesenchymal stem cells suppress human glioma growth through inhibition of angiogenesis. Stem Cells. 2013; 31:146-155.
-
(2013)
Stem Cells
, vol.31
, pp. 146-155
-
-
Ho, I.A.W.1
Toh, H.C.2
Ng, W.H.3
Teo, Y.L.4
Guo, C.M.5
Hui, K.M.6
Lam, P.Y.P.7
-
32
-
-
66149135956
-
Concentration-dependent inhibition of angiogenesis by mesenchymal stem cells
-
Otsu K, Das S, Houser SD, Quadri SK, Bhattacharya S, Bhattacharya J. Concentration-dependent inhibition of angiogenesis by mesenchymal stem cells. Blood. 2009; 113:4197-4205.
-
(2009)
Blood
, vol.113
, pp. 4197-4205
-
-
Otsu, K.1
Das, S.2
Houser, S.D.3
Quadri, S.K.4
Bhattacharya, S.5
Bhattacharya, J.6
-
34
-
-
84866307571
-
Cancer-stimulated mesenchymal stem cells create a carcinoma stem-cell niche via prostaglandin E2 signaling
-
Li HJ, Reinhardt F, Herschman HR, Weinberg RA. Cancer-stimulated mesenchymal stem cells create a carcinoma stem-cell niche via prostaglandin E2 signaling. Cancer Discov. 2012; 2:840-855.
-
(2012)
Cancer Discov
, vol.2
, pp. 840-855
-
-
Li, H.J.1
Reinhardt, F.2
Herschman, H.R.3
Weinberg, R.A.4
-
35
-
-
79958837418
-
Tumor necrosis factor-a-activated human adipose tissue-derived mesenchymal stem cells accelerate cutaneous wound healing through paracrine mechanisms
-
Heo SC, Jeon ES, Lee IH, Kim HS, Kim MB, Kim JH. Tumor necrosis factor-a-activated human adipose tissue-derived mesenchymal stem cells accelerate cutaneous wound healing through paracrine mechanisms. J Invest Dermatol. 2011; 131:1559-1567.
-
(2011)
J Invest Dermatol
, vol.131
, pp. 1559-1567
-
-
Heo, S.C.1
Jeon, E.S.2
Lee, I.H.3
Kim, H.S.4
Kim, M.B.5
Kim, J.H.6
-
36
-
-
84922698934
-
Targeting VEGFR1-and VEGFR2-expressing non-tumor cells is essential for esophageal cancer therapy
-
Xu WW, Li B, Lam AK, Tsao SW, Law SY, Chan KW, Yuan QJ, Cheung AL. Targeting VEGFR1-and VEGFR2-expressing non-tumor cells is essential for esophageal cancer therapy. Oncotarget. 2015; 6:1790-1805.
-
(2015)
Oncotarget
, vol.6
, pp. 1790-1805
-
-
Xu, W.W.1
Li, B.2
Lam, A.K.3
Tsao, S.W.4
Law, S.Y.5
Chan, K.W.6
Yuan, Q.J.7
Cheung, A.L.8
-
37
-
-
0033848994
-
CXC chemokines in angiogenesis
-
Belperio JA, Keane MP, Arenberg DA, Addison CL, Ehlert JE, Strieter MDB. CXC chemokines in angiogenesis. J Leukoc Biol. 2000; 68:1.
-
(2000)
J Leukoc Biol
, vol.68
, pp. 1
-
-
Belperio, J.A.1
Keane, M.P.2
Arenberg, D.A.3
Addison, C.L.4
Ehlert, J.E.5
Strieter, M.D.B.6
-
38
-
-
2442621619
-
Case history: discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
-
Ferrara N, Hillan KJ, Gerber H, Novotny W. Case history: discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nat Rev Drug Discov. 2004; 3:391-400.
-
(2004)
Nat Rev Drug Discov
, vol.3
, pp. 391-400
-
-
Ferrara, N.1
Hillan, K.J.2
Gerber, H.3
Novotny, W.4
-
39
-
-
77953988924
-
Targeting the tumour vasculature: insights from physiological angiogenesis
-
Chung AS, Lee J, Ferrara N. Targeting the tumour vasculature: insights from physiological angiogenesis. Nat Rev Cancer. 2010; 10:505-514.
-
(2010)
Nat Rev Cancer
, vol.10
, pp. 505-514
-
-
Chung, A.S.1
Lee, J.2
Ferrara, N.3
-
40
-
-
84896716303
-
Antian-giogenesis beyond VEGF inhibition: A journey from antiangiogenic single-target to broad-spectrum agents
-
Limaverde-Sousa G, Sternberg C, Ferreira CG. Antian-giogenesis beyond VEGF inhibition: A journey from antiangiogenic single-target to broad-spectrum agents. Cancer Treat Rev. 2014; 40:548-557.
-
(2014)
Cancer Treat Rev
, vol.40
, pp. 548-557
-
-
Limaverde-Sousa, G.1
Sternberg, C.2
Ferreira, C.G.3
-
41
-
-
0034792393
-
Expression of interleukin 8 and its receptors in human colon carcinoma cells with different metastatic potentials
-
Li A, Varney ML, Singh RK. Expression of interleukin 8 and its receptors in human colon carcinoma cells with different metastatic potentials. Clin Cancer Res. 2001; 7:3298-3304.
-
(2001)
Clin Cancer Res
, vol.7
, pp. 3298-3304
-
-
Li, A.1
Varney, M.L.2
Singh, R.K.3
-
42
-
-
70349778937
-
Dynamic changes of interleukin-8 network along the colorectal adenoma-carcinoma sequence
-
Cui G, Yuan A, Goll R, Vonen B, Florholmen J. Dynamic changes of interleukin-8 network along the colorectal adenoma-carcinoma sequence. Cancer Immunol, Immunother. 2009; 58:1897-1905.
-
(2009)
Cancer Immunol, Immunother
, vol.58
, pp. 1897-1905
-
-
Cui, G.1
Yuan, A.2
Goll, R.3
Vonen, B.4
Florholmen, J.5
-
43
-
-
0033988162
-
Interleukin-8 as an autocrine growth factor for human colon carcinoma cells in vitro
-
Brew R, Erikson JS, West DC, Kinsella AR, Slavin J, Christmas SE. Interleukin-8 as an autocrine growth factor for human colon carcinoma cells in vitro. Cytokine. 2000; 12:78-85.
-
(2000)
Cytokine
, vol.12
, pp. 78-85
-
-
Brew, R.1
Erikson, J.S.2
West, D.C.3
Kinsella, A.R.4
Slavin, J.5
Christmas, S.E.6
-
44
-
-
84863707423
-
Influence of IL-8 on the epithelial-mesenchymal transition and the tumor microenvironment
-
Palena C, Hamilton DH, Fernando RI. Influence of IL-8 on the epithelial-mesenchymal transition and the tumor microenvironment. Future Oncol. 2012; 8:713-722.
-
(2012)
Future Oncol
, vol.8
, pp. 713-722
-
-
Palena, C.1
Hamilton, D.H.2
Fernando, R.I.3
-
45
-
-
17844397949
-
The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis
-
Brat DJ, Bellail AC, Van Meir EG. The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis. Neuro. Oncol. 2005; 7:122-133.
-
(2005)
Neuro. Oncol
, vol.7
, pp. 122-133
-
-
Brat, D.J.1
Bellail, A.C.2
Van Meir, E.G.3
-
46
-
-
84860249964
-
The CXCR2 antagonist, SCH-527123, shows antitumor activity and sensitizes cells to oxaliplatin in preclinical colon cancer models
-
Ning Y, Labonte MJ, Zhang W, Bohanes PO, Gerger A, Yang D, Benhaim L, Paez D, Rosenberg DO, Nagulapalli Venkata KC, et al. The CXCR2 antagonist, SCH-527123, shows antitumor activity and sensitizes cells to oxaliplatin in preclinical colon cancer models. Mol Cancer Ther. 2012; 11:1353-1364.
-
(2012)
Mol Cancer Ther
, vol.11
, pp. 1353-1364
-
-
Ning, Y.1
Labonte, M.J.2
Zhang, W.3
Bohanes, P.O.4
Gerger, A.5
Yang, D.6
Benhaim, L.7
Paez, D.8
Rosenberg, D.O.9
Nagulapalli Venkata, K.C.10
-
47
-
-
34547858510
-
Rho inhibition induces migration of mesenchymal stromal cells
-
Jaganathan BG, Ruester B, Dressel L, Stein S, Grez M, Seifried E, Henschler R. Rho inhibition induces migration of mesenchymal stromal cells. Stem Cells. 2007; 25:1966-1974.
-
(2007)
Stem Cells
, vol.25
, pp. 1966-1974
-
-
Jaganathan, B.G.1
Ruester, B.2
Dressel, L.3
Stein, S.4
Grez, M.5
Seifried, E.6
Henschler, R.7
-
48
-
-
84902576199
-
Islet-1 Overexpression in human mesenchymal stem cells promotes vascularization through monocyte chemoattractant Protein-3
-
Liu J, Li W, Wang Y, Fan W, Li P, Lin W, Yang D, Fang R, Feng M, Hu C, Du Z, Wu G, Xiang AP. Islet-1 Overexpression in human mesenchymal stem cells promotes vascularization through monocyte chemoattractant Protein-3. Stem Cells. 2014; 32:1843-1854.
-
(2014)
Stem Cells
, vol.32
, pp. 1843-1854
-
-
Liu, J.1
Li, W.2
Wang, Y.3
Fan, W.4
Li, P.5
Lin, W.6
Yang, D.7
Fang, R.8
Feng, M.9
Hu, C.10
Du, Z.11
Wu, G.12
Xiang, A.P.13
|